Drug Side Effects A-Z: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

All medicines have benefits and risks. The risks of medicines are the chances that something unwanted or unexpected could happen to you when you use them, such as BASOSQUAMOUS CARCINOMA. Side effects can be temporary or long-lasting, and vary in seriousness. It is important to monitor drugs for BASOSQUAMOUS CARCINOMA and any other side effects. Sometimes BASOSQUAMOUS CARCINOMA can be reduced with the right treatment.



Have You experienced BASOSQUAMOUS CARCINOMA?
What is BASOSQUAMOUS CARCINOMA?

Drug Side Effect Episodes associated with BASOSQUAMOUS CARCINOMA
avonex
Episodes: 1
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
forteo
Episodes: 4
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
humira
Episodes: 3
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
mercaptopurine
Episodes: 2
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
orencia
Episodes: 1
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
rebif
Episodes: 1
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
remicade
Episodes: 3
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More
xolair
Episodes: 1
Diagnosed with major depression.Side effects: cardiac failure, myocarditis More

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.We hope you found our information about b>BASOSQUAMOUS CARCINOMA.